ÇOCUKLARDA ASTIM ATAK TEDAVİSİ: REHBERLERLE PRATİK YAKLAŞIM

Yıl 2015, Cilt: 78 Sayı: 1, 13 - 22, 12.01.2015

Deniz Özçeker , Sinem Oral Cebeci Nermin Güler

https://doi.org/10.18017/iuitfd.d.13056441.2015.78/1.13-22

Öz

Astım; hastane ve acil başvurularına, okul kaybına neden olan çocukluk çağının en sık kronik hastalığıdır. Astım atağı; nefes darlığı, hışırtılı solunum, göğüste sıkışma ve baskı hissi, özellikle gece olan öksürük gibi semptomlarla, egzersiz toleransında azalma, beslenmede bozulma gibi günlük aktivitelerde bozulma ve bronkodilatatör ihtiyacında artma ve ekspiratuvar akım hızında azalma ile ortaya çıkar. Beş yaş altında ve üstünde olan çocukların anatomik ve fizyolojik özellikleri birbirinden oldukça farklı olduğundan hem kronik astım tedavisi hem de atak sırasında yapılması gerekenler bazı farklılıklar göstermektedir. Bu yazıda çocuklarda astım atağına yaklaşım güncel rehberler doğrultusunda değerlendirilecektir.

Anahtar Kelimeler

Astım, çocuk, özyönetim

APPROACH TO MANAGEMENT OF ASTHMA EXACERBATION IN CHILDHOOD WITH CURRENT GUIDELINES

Öz

Asthma is the most common chronic disease of childhood that causes hospital and emergency admissions and school absences. Asthma exacerbation is characterized by an increase in symptoms of shortness of breath, wheezing, chest tightness, nocturnal cough; decrease in exercise tolerance; reduced daily activities; increase in need of bronchodilators and decrease of expiratory flow rate. Management of chronic asthma and exacerbation shows some varieties, because the anatomical and physiological characteristics are quite different in children who are younger and older than 5 years old. In this article we evaluated current guidelines of asthma exacerbation in children

Anahtar Kelimeler

Asthma, child, self management

Kaynakça

• Akinbami LJ, JE Moorman, Liu X. Asthma prevalence,health care use, and mortality: United States, 2005-2009. Natl Health Stat Report. 2011;32:1-14.
• Beckhaus AA, Riutort MC, Castro-Rodriguez JA. Inhaled versus systemic corticosteroids for acute asthma in children. A systematic review. Pediatr Pulmonol. 2014;49:326-34.
• Bisgaard H, Hermansen MN, Loland L, Halkjaer LB, Buchvald F. Intermittent inhaled corticosteroids in infants with episodic wheezing. N Engl J Med. 2006 11;354:1998-2005.
• Bousquet J. Primum non nocere. Prim Care Respir J. 2005;14:122-3.
• Brooks LJ, Cloutier MM, Afshani E. Significance of roentgenographic hospitalized for asthma. Chest. 1982; 82:315-8.
• Brunette MG1, Lands L, Thibodeau LP. Childhood asthma: prevention of attacks with short-term corticosteroid treatment of upper respiratory tract infection. Pediatrics. 1988;81:624-9.
• Castro-Rodriguez JA, Rodrigo GJ. Beta-agonists through metered-dose inhaler with valved holding chamber versus nebulizer for acute exacerbation of wheezing or asthma in children under 5 years of age: a systematic review with meta-analysis. J Pediatr. 2004;145:172-7.
• Cates CJ, Welsh EJ, Rowe BH. Holding chambers (spacers) versus treatment of acute asthma. Cochrane Database Syst Rev 2013. for beta-agonist
• Chen AH, Zeng GQ, Chen RC, Zhan JY, Sun LH, Huang SK, at al. Effects of nebulized high-dose budesonide exacerbation of asthma in children: a randomized, double-blind, placebo-controlled study. Respirology. 2013;18:47-52. acute
• Cheuk DK, Chau TC, Lee SL. A meta-analysis on intravenous magnesium sulphate for treating acute asthma. Arch Dis Child 2005;90:74–7.
• Connett G, Lenney W. Prevention of viral induced asthma attacks using inhaled budesonide. Arch Dis Child. 1993;68:85-7.
• Ducharme FM1, Lemire C, Noya FJ, Davis GM, Alos N, Leblond H, et all. Preemptive use of high- dose fluticasone for virus-induced wheezing in young children. N Engl J Med. 2009;360:339-53.
• Fox GF1, Marsh MJ, Milner AD.Treatment of recurrent acute wheezing episodes in infancy with oral Pediatr.1996;155:512-6. prednisolone. Eur J double-blind, placebo-controlled,
• Griffiths B, Ducharme FM. Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children. Cochrane Database Syst Rev. 2013;8:CD000060.
• Guidelines for the Diagnosis and Management of Asthma (Expert Panel Report 3) National Heart, Lung,and Blood Institute-2007.
• Horeczko T, Wintemute GJ. Asthma vital signs at triage: home or admission (ASTHmA). Pediatr Emerg Care 2013;29:175–82
• http://www.cdc.gov/nchs/FASTATS/asthma.htm [accessed 09.03.09].
• Jat KR, Chawla D. Ketamine for management of acute exacerbations of asthma in children. Cochrane Database Syst Rev. 2012;11:CD009293.
• Masoli M, Fabian D, Holt S, Beasley R; Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA Dissemination 2004;59:469-78. report. Allergy.
• Mitra AAD, Bassler D, Watts K, Lasserson TJ, Ducharme FM. Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilators. Cochrane Database Syst Rev. 2005;18:CD001276.
• Oommen A, Lambert PC, Grigg J. Efficacy of a short course of parent-initiated oral prednisolone for viral wheeze in children aged 1-5 years: randomised controlled trial. Lancet. 2003;362:1433-8.
• Papadopoulos NG, Arakawa H, Carlsen KH, Custovic A, Gern J, Lemanske R, at al. International consensus on (ICON) pediatric asthma. Allergy. 2012 ;67:976-97.
• Powell C, Dwan K, Milan SJ, Beasley R, Hughes R, Knopp-Sihota JA, Rowe BH. Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database Syst Rev. 2012;12:CD003898.
• Powell C, Kolamunnage-Dona R, Lowe J, Boland A, Petrou S, Doull I, at al. MAGNETIC study group. Magnesium sulphate in acute severe asthma in children (MAGNETIC): a randomised, placebo- controlled trial. Lancet Respir Med. 2013;1:301-8.
• Qureshi F. Management of children with acute asthma in the emergency department. Pediatr Emerg Care. 1999;15:206-14.
• Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, at al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009;180:59-99.
• Rodrigo GJ, Rodrigo C. Continuous vs intermittent beta-agonists in the treatment of acute adult asthma: a systematic review with meta-analysis. Chest 2002; 122:160-5.
• Rodrigo GJ, Rodriquez Verde M, Peregalli V, Rodrigo C. Effects of short-term 28% and 100% oxygen on PaCO2 and peak expiratory flow rate in acute 2003;124:1312-7. trial. Chest
• Rowe BH, Bretzlaff J, Bourdon C, Bota G, Blitz S, Camargo CA. Magnesium sulfate for treating exacerbations of acute asthma in the emergency department. 2000;CD001490. Database Syst Rev.
• Rowe BH, Spooner C, Ducharme FM, Bretzlaff JA, Bota GW. Early emergency department treatment of acute Cochrane Database Syst Rev. 2001;CD002178.
• Simpson CR, Sheikh A. Trends in the epidemiology of asthma in England: a national study of 333,294 patients. J R Soc Med. 2010;103:98-106.
• Teoh L, Cates CJ, Hurwitz M, Acworth JP, van Asperen P, Chang AB. Anticholinergic therapy for acute asthma in children. Cochrane Database Syst Rev. 2012;4:CD003797.
• Travers AH, Milan SJ, Jones AP, Camargo CA, Jr., Rowe BH. Addition of intravenous beta (2)-agonist to inhaled beta(2)-agonists for acute asthma. Cochrane Database Syst Rev 2012; 12: CD010179.
• Vuillermin P, South M, Robertson C. Parent- initiated oral corticosteroid therapy for intermittent wheezing illnesses in children. Cochrane Database Syst Rev. 2006;19:CD005311.
• Zeiger RS, Mauger D, Bacharier LB, Guilbert TW, Martinez FD, Lemanske RF, at al. Daily or intermittent budesonide in preschool children with recurrent wheezing. N Engl J Med. 2011;365:1990- 2001.